I think they have been careful with the language they used in this ann. It would be a MASSIVE claim if they had said PAT-DX1 killed the cancer cells and would of needed more proof I believe. But this is encouraging.
Ann: Preliminary PAT-DX1 pharmacokinetics, page-22
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $7.864K | 1.175M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 4361931 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1358675 | 5 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| PAB (ASX) Chart |